| Literature DB >> 8784656 |
Abstract
Risperidone, a novel antipsychotic agent, is an antagonist of postsynaptic serotonin-2 and dopamine D2 receptors. In certain individuals, the hallucinogenic drug lysergic acid diethylamide (LSD) is associated with apparently lifelong continuous visual disturbances, characterized in DSM-IV as hallucinogen-persisting perception disorder (HPPD). Because the hallucinogenic mechanism of LSD is known to act in part at postsynaptic serotonin-2 receptors, it is noteworthy that three HPPD patients treated with risperidone reported an exacerbation of LSD-like panic and visual symptoms. We conclude that HPPD may be a relative contraindication for the use of risperidone.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8784656 DOI: 10.1097/00004714-199606000-00008
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN: 0271-0749 Impact factor: 3.153